SUSAN ANDERSON: Open Payments
NPI 1669815049 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 34 payments from 22 companies in 2025. Trend: 2023 $31 · 2024 $538 · 2025 $742
Food & beverage: $730Education: $12
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $67 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| ARRAY BIOPHARMA INC | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Cumberland Pharmaceuticals, Inc. | 1 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Eisai Inc. | 2 | $32 |
| Genentech USA, Inc. | 1 | $31 |
Products named: XTANDI, KEYTRUDA, LIBTAYO, VENCLEXTA, SANCUSO, XALKORI, CARVYKTI, Lenvima.
Industry payments across KY — which companies pay providers there.
